ANAYS SUAREZ: Open Payments
NPI 1063964583 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 87 payments from 16 companies in 2025. Trend: 2023 $1,044 · 2024 $1,629 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $302 |
| ABBVIE INC. | 13 | $243 |
| Lilly USA, LLC | 7 | $155 |
| Incyte Corporation | 8 | $137 |
| UCB, Inc. | 10 | $137 |
| Galderma Laboratories, L.P. | 6 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $98 |
| ConvaTec Inc. | 3 | $90 |
| GENZYME CORPORATION | 4 | $81 |
| PFIZER INC. | 2 | $68 |
Products named: TREMFYA, OPZELURA, Bimzelx, NEMLUVIO, RINVOQ, SKYRIZI, DUPIXENT, EBGLYSS.
Industry payments across FL — which companies pay providers there.
